Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ)
CNY 4.67
(-0.21%)
CNY 4.67
(-0.21%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 189.17 Million CNY | -57.7% |
| 2022 | 720.27 Million CNY | -22.17% |
| 2021 | 925.43 Million CNY | -17.56% |
| 2020 | 1.12 Billion CNY | -24.06% |
| 2019 | 1.47 Billion CNY | 22.51% |
| 2018 | 1.2 Billion CNY | 21.7% |
| 2017 | 991.52 Million CNY | -6.95% |
| 2016 | 1.06 Billion CNY | -6.48% |
| 2015 | 1.13 Billion CNY | 177.33% |
| 2014 | 410.82 Million CNY | 91.78% |
| 2013 | 214.2 Million CNY | -4.58% |
| 2012 | 224.49 Million CNY | -28.01% |
| 2011 | 311.83 Million CNY | 10.33% |
| 2010 | 282.64 Million CNY | 69.08% |
| 2009 | 167.17 Million CNY | 20.5% |
| 2008 | 138.73 Million CNY | -1.11% |
| 2007 | 140.29 Million CNY | 2.44% |
| 2006 | 136.95 Million CNY | -0.77% |
| 2005 | 138.02 Million CNY | 46.79% |
| 2004 | 94.02 Million CNY | 40.2% |
| 2003 | 67.06 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 125.82 Million CNY | -24.39% |
| 2024 Q3 | 102.6 Million CNY | -18.46% |
| 2024 Q1 | 166.4 Million CNY | 931.0% |
| 2023 Q2 | 115.24 Million CNY | -9.26% |
| 2023 Q1 | 127 Million CNY | 13.79% |
| 2023 Q4 | -20.02 Million CNY | -124.3% |
| 2023 FY | 304.64 Million CNY | -57.7% |
| 2023 Q3 | 82.41 Million CNY | -28.49% |
| 2022 Q3 | 159.74 Million CNY | -23.11% |
| 2022 Q1 | 241.18 Million CNY | -3.8% |
| 2022 FY | 720.27 Million CNY | -22.17% |
| 2022 Q4 | 111.6 Million CNY | -30.13% |
| 2022 Q2 | 207.73 Million CNY | -13.87% |
| 2021 Q4 | 250.7 Million CNY | 17.7% |
| 2021 FY | 925.43 Million CNY | -17.56% |
| 2021 Q1 | 264.04 Million CNY | 20.79% |
| 2021 Q2 | 197.68 Million CNY | -25.13% |
| 2021 Q3 | 212.99 Million CNY | 7.74% |
| 2020 Q1 | 277.52 Million CNY | 1.72% |
| 2020 Q2 | 335.74 Million CNY | 20.98% |
| 2020 Q3 | 290.71 Million CNY | -13.41% |
| 2020 FY | 1.12 Billion CNY | -24.06% |
| 2020 Q4 | 218.59 Million CNY | -24.81% |
| 2019 Q1 | 404.53 Million CNY | 29.57% |
| 2019 FY | 1.47 Billion CNY | 22.51% |
| 2019 Q4 | 272.82 Million CNY | -19.91% |
| 2019 Q3 | 340.65 Million CNY | -25.98% |
| 2019 Q2 | 460.23 Million CNY | 13.77% |
| 2018 Q1 | 255.6 Million CNY | 8.06% |
| 2018 FY | 1.2 Billion CNY | 21.7% |
| 2018 Q4 | 312.22 Million CNY | -3.64% |
| 2018 Q3 | 324.02 Million CNY | 2.93% |
| 2018 Q2 | 314.8 Million CNY | 23.16% |
| 2017 Q2 | 292.35 Million CNY | 11.95% |
| 2017 Q3 | 201.47 Million CNY | -31.09% |
| 2017 Q1 | 261.14 Million CNY | 23.26% |
| 2017 FY | 991.52 Million CNY | -6.95% |
| 2017 Q4 | 236.54 Million CNY | 17.41% |
| 2016 Q3 | 281.09 Million CNY | -4.45% |
| 2016 Q1 | 278.37 Million CNY | 16.96% |
| 2016 FY | 1.06 Billion CNY | -6.48% |
| 2016 Q4 | 211.87 Million CNY | -24.63% |
| 2016 Q2 | 294.19 Million CNY | 5.68% |
| 2015 FY | 1.13 Billion CNY | 177.33% |
| 2015 Q4 | 238.01 Million CNY | -10.67% |
| 2015 Q3 | 266.45 Million CNY | -20.4% |
| 2015 Q2 | 334.76 Million CNY | 11.55% |
| 2015 Q1 | 300.09 Million CNY | 49.25% |
| 2014 FY | 410.82 Million CNY | 91.78% |
| 2014 Q3 | 67.5 Million CNY | -10.7% |
| 2014 Q2 | 75.59 Million CNY | 13.41% |
| 2014 Q4 | 201.06 Million CNY | 197.85% |
| 2014 Q1 | 66.65 Million CNY | 0.52% |
| 2013 Q1 | 50.95 Million CNY | 446.18% |
| 2013 Q2 | 51.87 Million CNY | 1.81% |
| 2013 Q3 | 45.08 Million CNY | -13.09% |
| 2013 Q4 | 66.3 Million CNY | 47.09% |
| 2013 FY | 214.2 Million CNY | -4.58% |
| 2012 Q4 | 9.32 Million CNY | -81.92% |
| 2012 Q3 | 51.58 Million CNY | -34.77% |
| 2012 FY | 224.49 Million CNY | -28.01% |
| 2012 Q1 | 84.5 Million CNY | 13.91% |
| 2012 Q2 | 79.08 Million CNY | -6.42% |
| 2011 FY | 311.83 Million CNY | 10.33% |
| 2011 Q4 | 74.18 Million CNY | 0.34% |
| 2011 Q3 | 73.93 Million CNY | -11.34% |
| 2011 Q2 | 83.38 Million CNY | 3.8% |
| 2011 Q1 | 80.33 Million CNY | 16.91% |
| 2010 Q1 | 62.32 Million CNY | 19.13% |
| 2010 Q3 | 76.65 Million CNY | 2.26% |
| 2010 Q2 | 74.95 Million CNY | 20.28% |
| 2010 FY | 282.64 Million CNY | 69.08% |
| 2010 Q4 | 68.71 Million CNY | -10.35% |
| 2009 FY | 167.17 Million CNY | 20.5% |
| 2009 Q4 | 52.31 Million CNY | 42.31% |
| 2009 Q3 | 36.75 Million CNY | -19.67% |
| 2009 Q2 | 45.76 Million CNY | 41.52% |
| 2009 Q1 | 32.33 Million CNY | 89.0% |
| 2008 Q1 | 40.98 Million CNY | 16.54% |
| 2008 Q2 | 48.74 Million CNY | 18.92% |
| 2008 Q3 | 31.89 Million CNY | -34.56% |
| 2008 Q4 | 17.1 Million CNY | -46.36% |
| 2008 FY | 138.73 Million CNY | -1.11% |
| 2007 Q2 | 38.38 Million CNY | 29.91% |
| 2007 FY | 140.29 Million CNY | 2.44% |
| 2007 Q4 | 35.16 Million CNY | -5.45% |
| 2007 Q3 | 37.19 Million CNY | -3.09% |
| 2007 Q1 | 29.54 Million CNY | 9.41% |
| 2006 Q3 | 35.76 Million CNY | -4.48% |
| 2006 Q4 | 27 Million CNY | -24.48% |
| 2006 FY | 136.95 Million CNY | -0.77% |
| 2006 Q2 | 37.44 Million CNY | 1.88% |
| 2006 Q1 | 36.74 Million CNY | -2.88% |
| 2005 FY | 138.02 Million CNY | 46.79% |
| 2005 Q3 | 34.19 Million CNY | 0.0% |
| 2005 Q4 | 37.84 Million CNY | 10.66% |
| 2004 FY | 94.02 Million CNY | 40.2% |
| 2003 FY | 67.06 Million CNY | 0.0% |